PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,000 | -100.0% | 255 | -100.0% | 0.00% | -100.0% |
| Q4 2015 | $3,141,000 | -39.5% | 887,214 | -14.0% | 0.53% | -32.1% |
| Q3 2015 | $5,189,000 | -22.2% | 1,031,540 | -0.6% | 0.78% | -18.8% |
| Q2 2015 | $6,672,000 | -15.3% | 1,037,600 | -7.3% | 0.97% | -5.0% |
| Q1 2015 | $7,878,000 | -7.8% | 1,119,794 | +1.1% | 1.02% | -11.0% |
| Q4 2014 | $8,540,000 | -11.9% | 1,107,698 | -14.7% | 1.14% | -10.8% |
| Q3 2014 | $9,699,000 | – | 1,298,459 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |